Evonik stock trades at EUR 21.30, 1.1 percent below its 52-week high

Published on 10/09/2026 at 15:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evonik stock costs EUR 21.30 on October 9, 2026, up 1.14 percent from EUR 21.06. The high is EUR 21.54 and market cap is EUR 9.9 billion.

Key points in brief

Evonik stock was at EUR 21.30 at Lang & Schwarz on October 9, 2026, up 1.14 percent from EUR 21.06.
The price stood 1.1 percent below the EUR 21.54 52-week high.
Market capitalization was EUR 9.9 billion and the P/E ratio was 82.4 as of October 9, 2026.
Berenberg raised its target from EUR 15.50 to EUR 20.00 on October 5, 2026, while retaining a Hold rating.

Aquarellmalerei der Essener Skyline mit Villa Hügel und Industriesilhouetten am Baldeneysee — Evonik Industries DE000EVNK013 als Aquarellmalerei der Essener Stadtlandschaft mit Industriesilhouette am Baldeneysee, Illustration mit AI erstellt.

Evonik stock was trading at EUR 21.30 at Lang & Schwarz on October 9, 2026, at 3:06 p.m. CEST, up 1.14 percent from the prior close of EUR 21.06. The move keeps the shares close to their yearly peak while the next results date remains a defined calendar event.

Trading activity remains below average

The bid was EUR 21.28 and the ask EUR 21.32 at the Lang & Schwarz snapshot. Trading volume stood at 516,746 shares at 2:50 p.m. CEST, versus an average volume of 1,308,479 shares.

Evonik's 52-week range was EUR 12.49 to EUR 21.54 as of October 9, 2026. At EUR 21.30, the stock stood 1.1 percent below the 52-week high and 70.5 percent above the 52-week low.

Valuation has several reference points

Evonik's market capitalization was EUR 9.9 billion and its P/E ratio was 82.4 on October 9, 2026. The trailing dividend yield was 0.1 percent, giving investors three distinct reference points for the current quotation.

As Yahoo Finance reported on October 5, 2026, Berenberg raised its target from EUR 15.50 to EUR 20.00 and upgraded Evonik from Sell to Hold. The target was 6.1 percent below the Lang & Schwarz price, a comparison that places the analyst view below the current quotation.

Comparison with peers

Evonik: plus 1.14 percent, P/E 82.4, market capitalization EUR 9.9 billion
BASF (Xetra, EUR): minus 0.27 percent, P/E 7.8, market capitalization EUR 44.5 billion
Covestro (Xetra, EUR): unchanged, P/E minus 23.8, market capitalization EUR 12.5 billion

The comparison uses October 9, 2026 market figures. Evonik's daily gain was positive while BASF declined 0.27 percent and Covestro was unchanged, but the three companies showed sharply different valuation measures.

Third-quarter date is November 3

Evonik's investor-relations calendar lists November 3, 2026 for its third-quarter reporting. The date gives the market a fixed point for testing the current quotation against the company's next reported operating figures, without adding a new price forecast.

Price remains near the yearly high

Evonik was trading at EUR 21.30 at Lang & Schwarz on October 9, 2026 at 3:06 p.m. CEST, plus 1.14 percent versus the Lang & Schwarz prior close of EUR 21.06 on October 8, 2026. The price was EUR 0.24 below the 52-week high of EUR 21.54.

The further course of trading is shown by the continuously updated real-time quote of Evonik stock.